Alpha Cognition Inc.

ACOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025
Revenue $10.2M
Cost of Revenue $603.4K
Gross Profit $9.6M
Gross Margin 94.1%
Operating Expenses
Research & Development $1.9M
SG&A Expense $29.1M
Operating Income $-22.7M
Operating Margin -221.7%
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-20.7M
Net Margin -202.2%
EPS (Basic) $-1.17
EPS (Diluted) $-1.18
Shares Outstanding (Basic) 17.7M
Shares Outstanding (Diluted) 17.7M
Dividends Per Share